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ABSTRACT 
 
 
 
Streptococcus pyogenes, the etiologic agent for several life-threatening invasive diseases, 
utilizes numerous mechanisms to evade the host immune response and establish a 
successful infection causing a significant source of morbidity and mortality risks for 
patients. The bacterium is known to cause necrotizing fasciitis in both humans and 
zebrafish, with extensive necrotic damage to tissues but surprisingly lacking in an 
inflammatory response for a systemic infection. This suggests that the recruitment of 
inflammatory cells to the site of infection is inhibited. To observe this in real-time, we used 
the zebrafish model of Streptococcal pathogenesis to analyze immune cell recruitment in 
the attenuated putative ABC transporter permease mutant, SalY, and lantibiotic mutant, 
SalA, to explain the difference in virulence as compared to wild-type. Fluorescence 
microscopy using transgenic zebrafish with fluorescent immune cells reveals increased co-
localization with macrophages in larvae infected with SalY mutant and a two-fold increase 
in the number of macrophages recruited early on to the site of infection compared to wild 
type. Bacterial recovery of SalY-mutant infection significantly decreased by nearly 85% 
compared to wild type. SalA mutant exhibited comparable observations to SalY mutant in 
immune cell recruitment and bacterial recovery. Further characterization of conserved 
genes of the Salivaricin locus in relation to their function in immunity will provide insight 
into a new mechanism for immune evasion and potentially lead to the development of novel 
antimicrobials to help address the significant healthcare burden posed by this pathogen.  
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 1 
INTRODUCTION 
 
 
 
Microbial pathogenesis is a dynamic interplay between the virulence factors 
expressed by the pathogen and the immune response elicited by the host upon infection 
(40). This host-pathogen interaction ultimately determines the disease progression and 
outcome (6); ranging from acute to life-threatening. The use of an animal model has made 
considerable advancements in understanding virulence genes in clinically important 
microorganisms. In this study, we used zebrafish larvae as the model host to analyze the 
Salivaricin locus of Streptococcus pyogenes, the etiologic agent for numerous human 
diseases, and how it affects the innate immune response to infection. Our goal in this 
project was to further characterize the genes of the Salivaricin locus in relation to their 
function in immunity that enables the pathogen to evade the host immune response and 
establish a successful infection; as well as, potentially leading to the development of novel 
antimicrobials to help address the significant healthcare burden induced by this pathogen. 
 
Group A Streptococcus 
Streptococcus pyogenes (Group A Streptococcus or GAS) is a Gram-positive, 
nonmotile, beta-hemolytic, facultative anaerobic coccus (2). The bacterium strictly infects 
humans where it colonizes the skin and nasopharynx and commonly causes noninvasive 
infections including acute pharyngitis and impetigo (5). Although rare in developed 
nations, invasive infections including cellulitis, necrotizing fasciitis, rheumatic fever, and 
streptococcal toxic shock syndrome (STTS) are often severe and life-threatening and 
requires immediate medical intervention. GAS is a common pathogen worldwide 
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responsible for more than half a million deaths each year (3, 4). In the United States, 
invasive GAS infections are estimated to have an incidence rate of 4 per 100 000 patients 
(5). Despite this low incidence rate, invasive GAS infections in the United States remain a 
significant source of morbidity and mortality. The prevalence of invasive infections caused 
by S. pyogenes in underdeveloped nations, however, is high with a mortality rate of up to 
30% (2) and continues to remain a significant health care issue to this day. With the 
emergence of antibiotic-resistant strains, the development of novel antimicrobial therapies 
is necessary to combat future incidences of life-threatening streptococcal infections.  
 
Group A Streptococci Pathogenesis 
S. pyogenes encodes for numerous virulence factors that allow for evasion of the 
host innate immune response enabling the pathogen to colonize and invade tissues. 
Adhesion and invasion of host tissue are important initial steps into invasive GAS 
infections. The M1 strain of S. pyogenes, a common serotype associated with invasive 
diseases, expresses fibronectin-binding protein of group A streptococci type A (FbaA) on 
its surface which binds to fibronectin-binding proteins on human epithelial cells (3, 7, 8). 
Mutants deficient in FbaA exhibit decreased binding to epithelial cells compared to wild 
type strain indicating that the FbaA protein is necessary for attachment and invasion (3). 
The M protein is also known to function in adherence to epithelial cells to aid the organism 
in colonization. The protein is a helical coiled-coil protein containing a conserved 
hexapeptide sequence, LPXTGE, preceding the C-terminal membrane anchor shared by 
many other Streptococcal species (11, 12). In addition to being anti-phagocytic, B cell-
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generated antibodies against the M protein are known to cross-react with smooth muscle 
cells in the heart, thus clinically manifesting as rheumatic fever (2).  
Evading the host immune response is critical for survival for any pathogen. 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expressed by S. pyogenes works in 
tandem with Streptococcal C5a peptidase to suppress the inflammation response and 
neutrophil migration to the site of infection by cleaving the complement component C5a 
(3, 9). C5a functions both as an anaphylatoxin and a chemoattractant mediating the release 
of proinflammatory molecules and initiating the recruitment of immune cells, respectively. 
In a study by Hong et al., a S. pyogenes strain possessing a mutated GAPDH that was 
retained in the cytoplasm resulted in downregulated expression of virulence genes and 
attenuated virulence (10). This highlights the direct role in GAS pathogenicity and 
importance of GAPDH as a surface protein in GAS survival. Streptococcal chemokine 
protease (ScpC) and DNase B are also virulence factors that aid S. pyogenes in evading the 
innate immune response. Homologous to Streptococcal C5a peptidase, ScpC is a serine 
protease that degrades interleukin-8 thereby preventing the recruitment of neutrophils to 
the site of infection (13). Neutrophils are known to utilize a unique method to kill 
extracellular pathogens via secretion of DNA fibers referred to as neutrophil extracellular 
traps (NETs). S. pyogenes can protect itself from NETs and continue spreading infection 
by secreting DNase B which hydrolyzes double-stranded nucleic acid sequences (14).  
 The spread of GAS infection is further assisted by other virulence factors to 
overcome the anatomical barriers encountered in the host. Streptokinase proteolytically 
cleaves plasminogen into plasmin; a serine protease that degrades plasma proteins 
including fibrin that is responsible for clot formation. This enables invasive GAS infections 
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to spread throughout the host via hematogenous route and colonize new tissues. Prior to 
entering the bloodstream, S. pyogenes must be able to spread through epithelial tissue. 
Streptococcal hyaluronidase breaks down connective tissue by hydrolyzing hyaluronic 
acid, therefore facilitating spread of GAS into deep tissue layers and consequently the 
bloodstream (15).  
 
Lantibiotics and The Salivaricin Locus 
Throughout evolution bacteria have acquired strategies to out-compete rivaling 
species in the environment for limited resources. One strategy is to produce antimicrobial 
substances called bacteriocins to inhibit growth or to kill closely related species (18). Many 
Gram-positive bacteria including S. pyogenes exclusively produce a specific class of 
bacteriocins referred to as lantibiotics. Lantibiotics (Class I bacteriocins) are polycyclic 
thioethers containing lanthionine and methyllanthionine formed by cross-linked cysteine 
residues to either 2,3-didehydroalanine (DHA) or (Z)-2,3-didehydrobutyrine (DHB) (19). 
A series of chemical modifications to serine and threonine in the cell synthesize these α, β-
unsaturated residues, DHA and DHB, respectively, that are then attacked by the thiol group 
of cysteine and, therefore, undergo an intramolecular cyclization to form the polycyclic 
structure (22). These small cationic peptides (<5,000 Da) work by killing closely related 
Gram-positive bacteria inhabiting and competing for the same environment by increasing 
the membrane permeability (20, 21, 23).  
 Salivaricin A (SalA) is a lantibiotic produced by Streptococcus salivarius, a closely 
related organism to S. pyogenes. Structurally, the lantibiotic is a 22-residue long (2,315 
Da) peptide containing one lanthionine and two methyllanthionine resides after 
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posttranslational modifications (24). As with most lantibiotics, SalA increases the 
membrane permeability of its target bacterium by functioning as a cytotoxic pore-forming 
toxin causing an influx and efflux of ions and molecules across the membrane that 
eventually triggers cell death (17, 25). The gene salA which encodes for SalA pre-peptide 
is a part of an operon of genes that is highly regulated at the transcriptional level to ensure 
synthesis at the appropriate time (26, 27).  
 
 
Figure 1: Proposed mechanism of the sal locus of S. salivarius.  
 
 The salivaricin (sal) locus of S. salivarius is composed of seven genes involved in 
the production, transport, and self-immunity of the lantibiotic peptide (Fig. 1). When the 
locus is activated, a 55-residue long SalA prepeptide is produced first which then gets 
modified and processed by SalM, encoded by salM, to form pre-SalA. Next, salT encodes 
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for the transmembrane transport protein, SalT, and cleaves pre-SalA into 22-residue long, 
fully functional SalA while also transporting the peptide into the extracellular environment 
(16, 17, 24). Lantibiotic-producing species must protect itself from the bactericidal effect 
of its own lantibiotic. The genes salX and salY in S. salivarius encode for immunity 
proteins: SalX and SalY, putative ATPase and transporter permeases, respectively (1, 17, 
28). This locus is regulated by the protein products of salK and salR. SalK and SalR are 
part of a two-component regulatory system where SalK (a histidine kinase) phosphorylates 
SalR (a response regulator) upon binding to SalA to regulate SalA production at the 
transcriptional level (28, 29).  
S. pyogenes also possesses the sal locus with approximately 85% sequence 
homology to the sal locus of S. salivarius. However, studies have shown that S. pyogenes 
is susceptible to salivaricin A produced by S. salivarius (16). A comparison between the S. 
salivarius and S. pyogenes sal loci reveal either deletions, mutations, or truncations in the 
processing gene salM and the transport gene salT in S. pyogenes suggesting the sal operon 
has been repurposed for a different function (30); whereas the other genes within the S. 
pyogenes sal locus, salA and salXYKR, remain highly conserved (17). Therefore, S. 
pyogenes is not able to synthesize an active SalA peptide with bactericidal activity. The 
fact that S. pyogenes is sensitive to SalA of S. salivarius, suggests that the SalXY are no 
longer acting in protection of the cell, even though they are still highly conserved. 
Therefore, the purposes and roles of each gene in the sal locus of S. pyogenes in survival 
and virulence remains elusive. We hypothesize that the loss of function of SalY will result 
in a significant difference in immune response compared to wild type-infected zebrafish 
larvae by analyzing recruitment of phagocytic cells in real-time.   
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Zebrafish Model of Pathogenesis 
To address the growing need of an alternative animal model to analyze host-
pathogen interaction of a bacterial infection in vivo, zebrafish (Danio rerio) has recently 
become a popular model organism for pathogenesis studies for several reasons. First is the 
possession of immune system that is similar to humans. Unlike traditional models such as 
Arabidopsis thaliana and Caenorhabditis elegans that only have features of innate 
immunity, zebrafish have both innate and adaptive immunity allowing researchers to 
analyze disease progression and outcomes of human pathogens (35, 37). Zebrafish innate 
immunity consist of the complement pathway, leukocytes, and phagocytic cells including 
macrophages and neutrophils, while adaptive immunity consists of B and T cells — all of 
which found in our immune system (34, 38, 39). Second, zebrafish larvae are transparent, 
which allows researchers to observe disease progression in vivo when using fluorescently-
labeled bacteria and analyzing infected embryos under a microscope (32, 33, 36). 
Therefore, this embryonic stage is attractive in real-time pathogenesis studies. Lastly, their 
affordability, ease of handling, and rapid development allowed zebrafish to be widely used 
in microbial pathogenesis studies; expanding our understanding on both marine and non-
marine pathogens (6, 34).  
 Neely et al. first described adult zebrafish being susceptible to S. pyogenes infection 
after noticing similarities in disease caused by fish pathogen Streptococcus iniae (6). 
Contrasting to S. iniae, S. pyogenes infection involves a lack of inflammation and extensive 
necrotic damage to dorsal muscles early on, suggesting inhibited recruitment of 
inflammatory cells to the site of infection (6). The bacterium is also capable of intracellular 
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survival in zebrafish macrophages in vivo to prevent destruction and subsequent antigen 
presentation on MHC-II to initiate adaptive immunity (1).  
 The zebrafish model of Streptococcal pathogenesis continues to provide insight on 
host-pathogen interaction and characterization of virulence-associated genes in S. pyogenes 
(6). Demonstrated by Phelps et al., SalY mutant strains showed attenuated virulence and 
inhibited survival in zebrafish macrophages despite expressing virulence factors involved 
in intracellular survival in host cells (1). Carrageenan-treated zebrafish, which depletes 
macrophage activity, restored SalY mutant virulence compared to control fish showing that 
loss of macrophages benefits the survival of the mutant strain (1). This attests to the SalY 
protein of S. pyogenes playing a role in virulence and suggests that the protein has an 
unknown function involving immunity against macrophages during an infection (1). 
However, the attenuated virulence and inhibited intracellular survival of SalY mutants was 
demonstrated in adult zebrafish, but not in zebrafish larvae. It is still unknown whether the 
macrophages migrate to the site of infection or are killed due to toxicity to explain the 
difference in virulence between wild-type and Sal mutant strains of S. pyogenes. Taking 
advantage of the zebrafish larvae’s optical transparency (31), will allow us to observe in 
real-time any potential differences in the immune response between wild-type and Sal 
mutants and whether Sal mutants are less virulent when infecting at this embryonic stage.  
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MATERIALS & METHODS 
 
 
 
Bacterial strains and zebrafish lines. Strains and lines used in this study are listed 
in Table 1.  
Strain/Line Genotype or description Reference 
S. pyogenes   
HSC5WT-8D4 emm Type 14, wild type (41) 
SalY-4A34 emm Type 14, SalY– (1) 
SalA-4A56 SF340 M type 1, SalA– (42) 
D. rerio    
ZF1 wild type  (43) 
Mpeg Tg(mpeg1:EGFP) (44) 
MPX Tg(mpx:GFP) (45) 
TABLE 1: Bacteria and zebrafish used in this study 
 
Media and growth conditions. The S. pyogenes growth medium was Todd-Hewitt 
medium supplemented with 0.2% yeast extract and 3% proteose peptone (TP). Cultures 
were grown in TP overnight at 37°C without shaking in 15-mL conical tubes and diluted 
1:50 in fresh TP the next day to bring the culture to mid-log phase.  
 
Growth curve.  S. pyogenes HSC5-WT was cultured in Todd-Hewitt-Yeast broth 
(ThyB) and TP at 37°C overnight.  The following morning a 1:50 subculture is made into 
fresh media, respectively, and incubated at 37°C for 1 hr.  The subculture is then analyzed 
by measuring the absorbance optical density at 600nm (OD600) using a spectrophotometer 
every 45 min.  Aliquots of each subculture are taken and subsequently 10-fold serially 
diluted out to 10-7 when absorbance readings of approximately 0.150, 0.200, 0.250, and 
0.300 are recorded.  To determine the colony forming units (CFUs) at each specific OD600 
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of HSC5-WT, 100 µL of 10-6 and 10-7 dilutions of each OD600 are plated onto Todd-
Hewitt-Yeast agar (ThyA) and incubated at 37°C, 5% CO2 for 24 hr. It is expected that 1 
x 108 CFU/mL corresponds to an absorbance OD600 of 0.225.  
 
Zebrafish breeding. Breeding cages were set up overnight and male and female ZF1 
zebrafish were separated with dividers to prevent natural spawning. The dividers were 
removed the following morning to allow the zebrafish to spawn. After spawning, breeding 
pairs were transferred back to original tanks and the embryos were collected using a 
transfer pipet into a sterile Petri dish containing embryo water. Unfertilized embryos are 
removed remaining embryos are transferred into another sterile Petri dish containing 
embryo water + 0.1% methylene blue.  Incubate at 29°C for 48 hr.  
 
Injection of zebrafish larvae. Subculture S. pyogenes HSC5-WT, SalY, and SalA 
mutants 50-fold into fresh TP and incubate at 37°C until OD600 is 0.225 (corresponding 
to 1 x 108 CFU/mL).  Inoculums for injection of 1, 5, 10, 100, and 1000 CFUs are prepared 
and placed on ice. 
Fish used for microinjections were prepared by euthanizing 3 days-post-
fertilization (dpf) embryos into fish water + 320 µg/mL Tricaine (pH: 6.98) for several 
minutes. Place 3% methylcellulose onto injection agar plate and position 20 larvae facing 
the same direction. Inject 1 nL of TP containing 10% phenol red using a calibrated 
microinjector into the yolk sac to serve as the negative control. Fish were subsequently 
washed in Petri dish containing fresh embryo water without Tricaine and immediately 
place fish into corresponding well of a 6-well plate. Repeat this for each dose of bacteria 
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as well as for injections into the otic vesicle. Incubate at 29°C and monitor fish for three 
days. Euthanized larvae will then be fixed for imaging by microscopy.  
 
Fixation and imaging. MPX and Mpeg zebrafish larvae injected into the otic vesicle 
at an inoculum of 1000 CFUs of each strain were euthanized at 1 and 2 hours-post-injection 
(hpi). Immediately following euthanization, larvae are fixed by placing into 4% 
paraformaldehyde at 4°C for 2 hr. Infected larvae were then washed three times with PBS 
+ 0.1% Tween and stored at 4°C until imaging. Prepared larvae were individually placed 
into a glass-bottom 24-well plate containing 0.4% agarose and incubated at 4°C for 10 min. 
Samples were analyzed under a fluorescent microscope to observe innate immune response 
to infection.  
 
Bacterial burden. Zebrafish injected into the otic vesicle at an inoculum of 50 CFUs 
of each strain were euthanized in Tricaine (320 µg/mL, pH: 6.98) 2 hpi, and 5 larvae 
infected from each strain were placed into separate 1.5-mL microcentrifuge tube containing 
200 µL PBS. Fish were homogenized, plated onto ThyA, and incubated at 37°C, 5% CO2 
for 24 hr to determine bacterial colonization.  
 
ImageJ analysis. Fluorescence images of neutrophil and macrophage recruitment 
in infected larvae at the site of infection were quantified using particle analysis function on 
ImageJ (https://imagej.nih.gov/ij/) (49).  
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Statistical analysis. Statistical significance of data was determined using two-tailed 
t test on the Data Analysis function from Analysis ToolPak on Microsoft Excel 2016.  
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RESULTS 
 
 
 
Growth curve in ThyB and TP. To determine which media will efficiently achieve 
the desired concentration of bacteria for inoculum preparation to be used in microinjection 
of zebrafish larvae, a growth curve was developed comparing media-rich TP and non-
media rich ThyB. S. pyogenes HSC5, serotype M14, exponentially grew under both media-
rich and non-media-rich conditions while in mid-log phase with a doubling time of 
approximately 40 min. When grown in media supplemented with 3% peptone (TP), S. 
pyogenes grew more rapidly than when grown without peptone (ThyB) by 0.43 orders of 
magnitude (Fig. 2). Absorbance reading corresponding to the targeted concentration of 1 x 
108 CFU/mL in TP was A600 = 0.225 after incubating for approximately 285 min after 
subculture. In ThyB, absorbance reading of A600 = 0.270 after approximately 350 min 
corresponds to 1 x 108 CFU/mL.  
 
 
Figure 2: S. pyogenes grows more rapidly under media-rich conditions. Growth curves of S. pyogenes 
HSC5, serotype M14, grown in Todd-Hewitt-Yeast + 3% peptone (TP) (black) and in Todd-Hewitt-Yeast 
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broth (ThyB) (blue). Absorbance readings were measure at 600 nm until A600 ≈ 0.5. Dotted lines represent 
exponential trend line with correlation coefficient of R2 = 0.92 (TP), 0.98 (ThyB). 
 
Dose response curve of wild type S. pyogenes in zebrafish larvae. A dose response 
curve of S. pyogenes HSC5 was performed to determine the optimal inoculum of bacteria 
into the zebrafish larvae for subsequent virulence studies. Larvae were injected with 
varying doses of S. pyogenes HSC5 into the yolk sac and survival was measured by fish 
remaining alive after 24 hours-post-injection (hpi). Larvae injected with 1 CFU showed 
high survival rate of 90% after 24 hpi whereas larvae injected with 100 and 1000 CFU 
showed very low survival of 10% and 0%, respectively, after 24 hpi when injected into the 
yolk sac (Fig. 3). Inoculums of 5 and 10 CFU resulted in survival rates of 42% and 30%, 
respectively, suitable for future studies with mutant strains to assess virulence.  
 
 
 
Figure 3: S. pyogenes causes highly lethal infection in zebrafish larvae. Dose response curve of S. 
pyogenes HSC5, serotype M14, infection in ZF1 zebrafish larvae into the yolk sac at various concentrations. 
Survival to infection was monitored after 24 hpi. Error bars represent ± SEM. n = 20. 
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Virulence of sal mutants in zebrafish larvae. To assess virulence of sal mutants 
compared to wild type S. pyogenes HSC5 in zebrafish larvae, strains of wild type (HSC5), 
SalY and SalA mutants, were first injected into the yolk sac at 10 CFU to model a systemic 
infection and monitored every 24 hr for 3 days. After 24 hpi, zebrafish larvae show a slight 
increase in survival when infected with either sal mutant (Fig. 4A), but not statistically 
significant (p > 0.1). Infected larvae with mutant strains continued to show increased 
survival after 48 hpi with 15% and 20% survival with SalY and SalA (p ≤ 0.05), 
respectively, compared to 10% survival with wild type (Fig. 4B). No change in percent 
survival was detected after 72 hpi (Fig. 4C).  
 Zebrafish larvae were later injected with strains into the otic vesicle to model a 
localized infection where the bacterium has no access to enter circulation. Inoculums of 50 
and 100 CFUs were chosen based on the assumption that higher dosages are necessary to 
assess virulence when modeling a localized infection. After 24 hpi, larvae infected with 
SalY mutant show decreased survival compared to wild type at 100 CFU (Fig. 5A), 
contrary to what was expected based on infections in the yolk sac but no statistically 
significant (p > 0.1). However, the SalA mutant has increased survival compared to wild 
type at 50 and 100 CFU (p > 0.1) (Fig. 5A). Larvae infected with either the SalY or SalA 
mutant strain had decreased survival compared to wild type after 48 hpi, with the exception 
of 50 CFU of the SalY mutant showing increased survival, particularly with 100 CFU of 
SalY (p ≤ 0.1) and SalA (Fig. 5B). Decreased survival was continued after 72 hpi with 
mutant-infected larvae at 100 CFU (SalY: p ≤ 0.1, SalA: p ≤ 0.05), while 50 CFU of SalY 
continued to show increased survival (no significance, p > 0.1) (Fig. 5C).  
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Figure 4: sal mutant strains demonstrated increased survival in zebrafish larvae in yolk sac infection. 
Infection to WT S. pyogenes (HSC5) and sal mutant strains (10 CFU) in ZF1 zebrafish larvae into the yolk 
sac was monitored 24 (A), 48 (B), and 72 hpi (C) for survival. Data was normalized to the control. Error bars 
represent ± SEM. ** p ≤ 0.05. n = 20.  
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Figure 5: sal mutant strains demonstrated decrease survival in zebrafish larvae in localized infection. 
Infection of WT S. pyogenes and sal mutant strains in ZF1 zebrafish larvae into the otic vesicle was monitored 
24 (A), 48 (B), and 72 hpi (C) for survival. Data was normalized to the control. 50 = 50 CFU. 100 = 100 
CFU. Error bars represent ± SEM. * p ≤ 0.1, ** p ≤ 0.05. n = 20.  
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Analysis of neutrophil recruitment in S. pyogenes infection. To observe real-time 
immune cell recruitment to the site of infection, S. pyogenes was injected into the otic 
vesicle at 1000 CFU in transgenic zebrafish lines, fixed after 1 and 2 hpi, and analyzed 
under a fluorescent microscope. Due to the inability of obtaining a transgenic 
Streptococcus expressing GFP, bacteria were labeled with CellTrackerTM Red CMTPX 
(Life Technologies) to visualize under the fluorescent microscope. MPO transgenic 
zebrafish larvae (Table 1) were first studied to analyze neutrophil migration in response to 
a GAS infection. Control larvae infected with only TP media show successful recruitment 
of neutrophils to the otic vesicle after 1 hpi (Fig. 6A). Neutrophils are also present in the 
otic vesicle after 1 hpi when infected with wild type and mutant S. pyogenes, but the 
neutrophils are less concentrated at the otic vesicle and are more dispersed around the site 
of infection (Fig. 6A). Red fluorescent channel (excitation/emission: 558 nm/583 nm) 
reveals the presence of SalY and SalA mutants localized with the otic vesicle whereas wild 
type is less prominent within the otic vesicle. The overlay between the green 
(excitation/emission: 495 nm/519 nm) and the red channels show co-localization (direct 
overlap) between neutrophils and each strain of bacteria studied within the general area of 
the site of infection (Fig. 6A). SalY, in particular, shows co-localization in the duct of 
cuvier.  
 After 2 hpi, more neutrophils were present at the site of infection compared to 1 hpi 
in the larvae infected with the mutant GAS strains (Fig. 6B). The control and wild type-
infected larvae appeared to have fairly low green fluorescence within and around the otic 
vesicle. Red channel continues to indicate presence of GAS at the otic vesicle, with SalY 
migrating out of the vesicle (Fig. 6B). The overlay between the green and the red channels 
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reveal less co-localization in wild type-infected compared to mutant-infected larvae at the 
site of infection. The presence of SalY entering into circulation was not observed after 2 
hpi.   
 The number of neutrophils within the otic vesicle were quantified using particle 
analysis on ImageJ (Fig. 7). The mean number of neutrophils was higher in larvae infected 
with SalA mutant and lower with SalY mutant compared to wild type after 1 hpi, but neither 
were significant (p > 0.1) (Fig. 7A). Consistent with observations from imaging results, 
SalA infection at 2 hpi showed significantly more neutrophil recruitment to the otic vesicle 
compared to wild type (p ≤ 0.01) (Fig. 7B). The mean number of neutrophils in SalY 
infection was also higher, but statistically not significant (p > 0.1). Interestingly, the mean 
number of neutrophils decreased by nearly 50% in wild type-infected larvae between 1 and 
2 hpi (Fig. 7).  
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Figure 6: Neutrophils are recruited to the site of infection upon initial infection in both wild type and 
sal mutant strains. MPO transgenic zebrafish larvae infected with CellTrackerTM Red CMTPX-labeled S. 
pyogenes strains (1000 CFU) were analyzed under fluorescence microscope to track neutrophil migration to 
the otic vesicle after (A) 1 hpi and (B) 2 hpi. Green represents GFP-labeled neutrophils (FITC: 495 nm) and 
red represents S. pyogenes (DSRed: 558 nm). Overlay images of green and red channels depict the location 
of neutrophils upon infection with S. pyogenes. No bacteria were present in the controls.  
 21 
 
 
 
 
 
Figure 7: Infection with sal mutant strains results in increased number of neutrophils to the site of 
infection. Number of neutrophils in the otic vesicle after 1 (A) and 2 hpi (B) were quantified using particle 
analysis on ImageJ. Data was normalized to the control. Error bars represent ± SEM. ns = no significance. 
*** p ≤ 0.01 
 
 
Analysis of macrophage recruitment to S. pyogenes infection. Macrophage 
recruitment in response to GAS infection was then studied and analyzed using Mpeg1 
transgenic zebrafish larvae (Table 1). Control larvae infected with only TP media did not 
 22 
show recruitment of macrophage to the otic vesicle after 1 hpi (Fig. 8A). Macrophage are 
also absent in the otic vesicle and vicinity after 1 hpi when infected with SalY mutant. 
Wild-type and SalA-infected zebrafish did show recruitment of macrophages to the general 
site of the infection after 1 hpi, but these cells were not localized within the otic vesicle in 
wild-type-infected fish as they were with SalA infection. Red fluorescent channel reveals 
the presence of all three strains localized with the otic vesicle with SalA also spread to the 
hindbrain region (Fig. 8A). The overlay between the green and red channels does not show 
co-localization between macrophage and bacteria in wild-type and SalY-infected larvae. 
Co-localization is seen in the hindbrain region in SalA-infected larvae, but around the otic 
vesicle area (Fig. 8A).  
 After 2 hpi, more macrophages are recruited to the site of infection compared to 1 
hpi in larvae infected with SalY mutant (Fig. 8B). Red channel reveals that the SalY mutant 
has spread from the injection site. Macrophages are still present in wild type and SalA-
infected larvae within the vicinity of the otic vesicle at lower fluorescence intensity 
compared to 1 hpi. The overlay between the green and red channels reveal considerable 
co-localization with both sal mutant strains whereas with wild-type shows much less 
detectable co-localization between bacteria and macrophage (Fig. 8B). Control-infected 
larvae continued to show no detection of macrophages at the otic vesicle.  
 The number of macrophage within the otic vesicle and general vicinity of the site 
of infection were quantified using the same method of analysis for neutrophils (Fig. 9). The 
mean number of macrophage in SalA-infected larvae was 2X more compared to wild type 
after 1 hpi, but significance was not able to be determined (Fig. 9A). The absence of 
detectable macrophages in SalY infection compared to wild type after 1 hpi was not 
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significant (p > 0.1). Infection with SalY mutant showed a significant increase in the 
number of macrophage recruited to the site of infection of nearly 2X that compared to wild 
type after 2 hpi (p ≤ 0.05) (Fig. 9B). Infection with SalA mutant 2 hpi, however, resulted 
in a decrease in macrophages recruitment by approximately 40-percent compared to wild 
type (significance could not be determined) (Fig. 9B).  
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Figure 8: Macrophages are recruited to the site of infection upon initial infection in both wild type and 
sal mutant strains. Mpeg1 transgenic zebrafish larvae infected with CellTrackerTM Red CMTPX-labeled S. 
pyogenes strains (1000 CFU) were analyzed under fluorescence microscope to track macrophage migration 
to the otic vesicle after (A) 1 hpi and (B) 2 hpi. Green represents EGFP-labeled macrophage (FITC: 495 nm) 
and red represents S. pyogenes (DSRed: 558 nm). Overlay images of green and red channels depict the 
location of macrophage upon infection with S. pyogenes. No bacteria were present in the controls. 
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Figure 9: Infection with SalY mutant results in increased number of macrophages to the site of 
infection. Number of macrophages in the otic vesicle after (A) 1 hpi and (B) 2 hpi were quantified using 
particle analysis in ImageJ. Data was normalized to wild type (WT). Error bars represent ± SEM. ns = no 
significance. ** p ≤ 0.05 
 
 
Bacterial recovery. Infected zebrafish larvae were homogenized and plated on 
ThyA overnight to determine the number of S. pyogenes remaining after 2 hpi and to assess 
whether the immune response cleared the infection. The mean number of recovered SalY 
mutant was significantly lower compared to wild type (p ≤ 0.001); an approximate 85 
percent decrease over the course of 2 hours (Fig. 10). SalA mutant also showed a significant 
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decrease compared to wild type (p ≤ 0.01) with about 50 percent decrease in the mean 
number of bacteria recovered (Fig. 10).  
 
 
 
Figure 10: sal mutants show more clearance by immune cells after 2 hpi. Bacterial recovery of S. 
pyogenes strains infected into the otic vesicle at 50 CFU after 2 hpi. Zebrafish larvae homogenate was plated 
on Todd-Hewitt-Yeast agar overnight for isolation. Data was normalized to wild type (WT). Error bars 
represent ± SEM. *** p ≤ 0.01. **** p ≤ 0.001. n = 15.  
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DISCUSSION 
 
 
 
Evasion of the host immune response is essential for establishing a successful 
infection and is a defining attribute of a pathogen that differentiates itself from other 
microorganisms. Expression of virulence factors by the pathogen modulates the innate 
immune response to increase the chances of survival within the host. This strategic method 
has been uniquely adapted for each microbe throughout evolution to suit their individual 
obstacles as a means of enhancing fitness. In recent years, S. pyogenes, a common human 
pathogen worldwide responsible for a spectrum of diseases and disorders, has 
demonstrated the ability to cause extensive necrotic damage to skeletal muscle without 
inflammation that is commonly associated with a systemic infection (1). Such ability 
provides the pathogen with the advantage of not encountering cells of the immune response 
including phagocytes that would lead to death and ultimately immunological memory for 
the host. However, this would imply the bacterium is capable of blocking chemotactic 
signals required for recruitment or the release of cytotoxic factors that would deplete the 
phagocyte population. Using the zebrafish model of pathogenesis, we demonstrated 
recruitment of neutrophils and macrophages to the site of infection when infected with 
either S. pyogenes HSC5 or sal locus mutants early on during infection. Despite this 
observation, infection with sal locus mutants showed significant decrease in bacteria 
recovered compared to wild type-infected larvae.  
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Virulence of sal Locus Mutants in Systemic vs. Localized Infection 
The loss of function of the SalY protein in S. pyogenes has shown attenuated 
intracellular survival within macrophages when infecting adult zebrafish (1). Since 3 dpf 
larvae have not developed skeletal muscle tissue to replicate the necrotizing fasciitis 
phenotype as seen with S. pyogenes HSC5 infection, larvae were monitored for survival 
over the course of three days. Consistent with pervious observations with in vivo 
streptococci pathogenesis studies and with human infections (5, 6), data presented here 
supports the idea that S. pyogenes is a highly virulent pathogen that is especially lethal to 
zebrafish larvae. Infecting during the larval stage of development at a small inoculum 
concentration of 10 CFU of S. pyogenes HSC5 into the yolk sac is enough bacteria to kill 
approximately 70-percent in just 24 hpi (Fig. 3). Even reducing the inoculum by half only 
had slight improvement in survival by about 10-percent. The trend in lethality from the 
infection continues with roughly 90-percent after 48 hpi; a 67-percent reduction in survival 
from 24 hpi (Fig. 4B). This drastic decrease in survival supports clinical and 
epidemiological studies on invasive GAS infection in humans causing a significant 
increase in morbidity and mortality in patients (3 – 5). Injecting directly into the yolk sac 
allows the pathogen to cause a systemic infection without the need to express certain 
virulence factors to overcome anatomical barriers and non-specific immune responses to 
enter the bloodstream; thus, directly modeling an invasive GAS infection. Interestingly, 
virtually no change in survival was observed after 72 hpi suggesting the immune response 
may have cleared the infection to tolerable levels with minimal toxicity. 
 Unlike in adult zebrafish, the loss of function of the SalY protein causes slight 
attenuation in virulence in zebrafish larvae under systemic infection conditions. Over the 
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course of 72 hpi, the SalY mutant only exhibited approximately a 25-percent increase in 
survival after monitoring at 24-hour time points (Fig. 4). This small increase in survival 
was not statistically significant (p > 0.1) and therefore is inconsistent with previously 
described zebrafish infection using this sal mutant. Thus, this data suggests that SalY may 
not play a role in virulence when infecting at this early stage in embryonic development. 
Despite this inconsistency, SalA mutant observed more attenuation in virulence under the 
same conditions. After 48 hpi, survival in SalA mutant infected larvae doubled compared 
to wild type-infected larvae (p ≤ 0.05) (Fig. 4B) and this observation continued after 72 
hpi, suggesting that SalA does indeed play a role in virulence in S. pyogenes. Even with 
these respective loses of function in the sal locus, sal locus mutants still cause a lethal 
infection in the host (but at a lesser degree compared to HSC5). It is possible that there is 
a uniquely different host-pathogen interplay occurring with these mutants that needs further 
characterization to understand this interaction.  
 Furthermore, neither the loss of the SalY nor SalA proteins showed attenuation in 
virulence in zebrafish larvae under localized infection conditions. There was approximately 
a 50-percent decrease in survival in SalY mutant-infected larvae compared to wild type-
infected larvae at 48 and 72 hpi after inoculation into the otic vesicle (Fig. 5B & C) (p ≤ 
0.1), but this observation appears to be dose-dependent. Dose dependency in virulence was 
demonstrated by Stephens et al. in which high concentration of viable Listeria 
monocytogenes showed virulence in mice injected intravenously whereas low 
concentrations did not result in such effects (46). Using such a model, the enhanced 
virulence seen with SalY mutants occurred at a concentration of 100 CFU, whereas 
attenuation in virulence was seen with 50 CFU. This suggests that the dose of the bacterium 
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corresponds to the level of toxins expressed and released. Thus, it is possible that 100 CFU 
of S. pyogenes lacking functional SalY at a localized site has reached above the threshold 
of tolerance for the larvae. The SalA mutant showed greater virulence compared to the 
SalY mutant under the same conditions. But, unlike SalY where low doses result in 
attenuation, SalA at both 50 and 100 CFU show drastic decreases in survival in infected 
larvae after 48 and 72 hpi (Fig. 5B & C); with 100 CFU after 72 hpi resulting in 100-
percent decrease (p ≤ 0.05). This further implies a change in gene expression by the 
bacterium that differs from a systemic infection. An in-situ hybridization assay would be 
necessary to analyze expression profiles of sal mutants under both infection conditions to 
determine if a compensatory mechanism is upregulated due to the loss of SalY and SalA 
function is causing these unusual results in virulence.  
 
Neutrophils are Recruited First to GAS Infection followed by Macrophages 
The lack of inflammation at the site of infection, presence of bacteria aggregates, 
and no detection of macrophages after 24 hpi as previously demonstrated by Phelps et al. 
(1), indicate interference with immune cell recruitment; an essential part of the innate 
immune response to an infection. It is well established in the literature that neutrophils are 
the first-responders to and comprising the majority of leukocytes in response to wounds 
and infections (47). The data presented in this study is the first characterization of 
neutrophil recruitment to salivarivin locus mutants of S. pyogenes. In all three strains used 
neutrophils are recruited to site of infection after 1 hpi and co-localization between the 
bacterial strain and neutrophils are observed (Fig. 6A). Interestingly, it appears that 
neutrophils have taken the SalY-mutants out of the otic vesicle and carrying them into 
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circulation as seen with the presence of overlaid cells in the duct of cuvier. Since SalY 
mutants express a functional M protein, it is likely that the mutant is surviving 
intracellularly in these neutrophils and is inhibiting the fusion of granules with the 
phagosome to prevent destruction (2, 3, 7, 8). Similar results are observed after 2 hpi (Fig. 
6B) further suggesting that neutrophils are still the first-responders to infection. 
Quantifying the neutrophils off the fluorescent images using particle analyze on ImageJ 
demonstrated an increase in the average number of neutrophils recruited to the site of 
infection when infected with sal mutants (Fig. 7). After 2 hpi, there was a two-fold increase 
in the number of neutrophils with SalY and five times the number of neutrophils with SalA 
(p ≤ 0.05) compared to wild-type. The loss of either of these proteins causing increased 
chemotaxis of neutrophils implies that the salivaricin locus is involved in virulence and 
immune evasion in S. pyogenes, despite expressing ScpC and DNase B (13, 14). It is 
important to note that particle analysis on ImageJ is not a highly accurate method for 
quantifying fluorescent cells. Future quantification of neutrophils in infection studies to 
further characterize the salivaricin locus would need an alternative software or analysis 
function to count fluorescent cells.  
 Macrophages aid in the wound healing process as they replace neutrophils about 
two-day after the injury (48). This is consistent with observations made in zebrafish larvae 
as no macrophages are detected in or around the general vicinity of the otic vesicle in the 
control after 1 and 2 hpi (Fig. 8). Contrary to our hypothesis, macrophages are activated 
and recruited upon infection to wild type and SalA mutant after 1 hpi (Fig. 8A), with twice 
the number of macrophage in SalA-infected larvae compared to wild type-infected (Fig. 
9A). However, no macrophages were detected in SalY infection after 1 hpi. All three 
 32 
infections after 1 hpi do not show co-localization between bacteria and macrophage 
indicating that the macrophages have not yet entered the otic vesicle or are having difficulty 
sensing the foreign invader due to their dispersed distribution around the site of infection. 
After 2 hpi co-localization was observed with all three infections; SalY showing the highest 
degree of bacteria and macrophage overlapping (yellow fluorescence) (Fig. 8B). Minimal 
yellow florescence is seen with wild type and SalA mutant. The number of macrophages 
recruited to the site of infection with SalY mutant significantly doubled compared to wild 
type (p ≤ 0.05) whereas infection with SalA mutant drastically decreased by about 60-
percent (Fig. 9B). Together, these observations show that macrophages are indeed recruited 
and could be attempting to clear the infection, but little success is seen with the wild type 
strain of S. pyogenes HSC5. The salivaricin mutants still express functional streptolysin O 
and Spe B that facilitate evasion of lysosomal degradation in macrophage and thus, 
enabling intracellular survival (1, 3). Together, the analysis of fluorescently-labeled 
immune cell data suggests that the loss of function in the conserved regions of the 
salivaricin locus is involved in increased susceptibility to phagocytosis by macrophage 
cells.   
 
Enhanced Immune Clearance in sal Locus Mutant Infection 
Higher detection of co-localization seen with sal mutants implies enhanced uptake 
by immune cells and less freely-associated bacteria. Data presented in this study supports 
our hypothesis that infection with sal mutants would result in less bacteria recovered; an 
effect of having virulence attenuated. In comparison to the wild type, both SalA and SalY 
mutant infections resulted in significantly decreased bacterial colonies recovered after 2 
hpi (Sal A: p ≤ 0.01; SalY: p≤ 0.001) (Fig. 10). This data also correlates with histology 
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results of dorsal muscle tissue upon infection with S. pyogenes HSC5 and SalY mutant as 
demonstrated by Phelps et al. (1). Muscle tissue from a SalY infection after 24 hpi shows 
no bacterial aggregates as seen with the wild type infection, but the bacteria have been 
phagocytized by macrophages. Intracellular bacteria are not recovered on an agar plate and 
therefore, the loss of function in SalA and SalY enhances the innate immune response 
ability to sequester the pathogen and overall survival of the host.  
 
Summary 
As a whole, the data presented in this study supports the role of conserved regions 
in the salivaricin locus in full virulence in S. pyogenes HSC5. Analyzing mutant strains of 
SalA and SalY under the fluorescent microscope and recovering bacteria from infected 
zebrafish shows that these two proteins enhance pathogenicity in S. pyogenes. We 
introduced that SalY mutant-infection is dose-dependent at the larval stage of development 
in zebrafish under localized conditions. In addition, neutrophils and macrophages are 
recruited to the site of infection early after injection. The large number of macrophage co-
localized with SalY mutants yet few colonies recovered from SalY mutant-infection further 
supports the hypothesis that the SalY protein has evolved to recognize antimicrobial 
peptides secreted by macrophages, instead of Salivaricin A, to aid in intracellular survival 
(1). Likewise, the similar observations in SalA as seen with SalY also supports the 
hypothesis that SalA has another function other than acting as a bacteriocin (1). Even 
though S. pyogenes possess mutations in SalM and SalT that processes prepro-SalA into 
SalA, SalA may be processed by other proteins in the cell to serve its unknown function 
involving virulence. Further in vivo analyses and bacterial burdens at additional time points 
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will greatly add to our existing understanding of the sal locus in virulence. Furthermore, 
improving the fixation procedure by eliminating the paraformaldehyde and PBS-Tween 20 
wash as they interfere with the fluorescence intensity of the immune cells will allow greater 
visualization of the host-pathogen interactions. Assaying for macrophage factors to 
determine the substrate for the SalY protein will provide insight into this novel intracellular 
survival mechanism and aid in the development of new antimicrobials targeting this protein 
to address the significant morbidity and mortality caused by this pathogen worldwide.  
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APPENDIX 
 
From: Paula Portalatin <paula.portalatin@maine.edu> 
Subject: Protocol A2017-01-02 Approval 
Date: February 6, 2017 at 10:53:57 AM EST 
To: Melody Neely <melody.neely@maine.edu> 
 
Protocol #: A2017-01-02 
Protocol Title: Analysis of Streptococcal infection using the Zebrafish infectious disease model 
PI: Melody Neely 
Species/# Approved: Zebrafish (6-9 months) 4554 
                                  Zebrafish (4-7 days post fertilization) 23, 220 
Approval Period: 2/6/2017-2/5/2020 
 
Dear Melody, 
 
The above referenced protocol has been approved by the University of Maine IACUC. As a courtesy the 
IACUC Office will generally send out reminders for annual and de novo reviews however, it is ultimately 
the responsibility of the PI to ensure that the protocol is renewed on time. 
 
All of the proposed methods, procedures, and conditions have been approved AS STATED IN THE 
PROTOCOL APPLICATION. The IACUC must approve any changes or deviations from the approved 
protocol prior to being initiated. 
 
University of Maine Animal Welfare Assurance #:  A3754-01 
The University of Maine is registered as a research facility in accordance with the U.S. Department of 
Agriculture Animal Welfare Act and the Public Health Service Policy on the Humane Care and Use of 
Laboratory Animals. The University of Maine holds the Office of Laboratory Animal Welfare (OLAW) of 
the National Institutes of Health assurance for vertebrate animals used in research, teaching and outreach. 
 
The Animal Welfare Assurance (1) confirms the commitment that the University of Maine will comply 
with the PHS Policy, with the Guide for the Care and Use of Laboratory Animals, and with the Animal 
Welfare Regulation; (2) describes the institution's program for animal care and use; and (3) designates the 
institutional official responsible for compliance. 
 
I could not find a record indicating that Duc Nygen has completed the online IACUC training. Please 
notify me once the training is complete so that the person can be added to the protocol. 
Attached to this email you will find a cage card that should be posted on or near the tanks housing the fish. 
Thank you again for sending the revised protocol to the IACUC so quickly, good luck with your research. 
 
Sincerely, 
Paula 
 
--  
Paula Portalatin, M. Ed., CPIA 
Research Compliance Officer II 
Office of Research & Sponsored Programs 
University of Maine 
Room 402 Corbett Hall 
Orono, Maine 04469-5717 
(207) 581-2657 
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